Evidence map›Paper›PMID 12697726›Full record

ReviewThe Journal of clinical investigation2003

The organization and consequences of eicosanoid signaling.

Roy J Soberman, Peter Christmas

Abstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The CysLTProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Editorial: Signaling Proteins for Endosomal and Lysosomal Function.Frontiers in cell and developmental biology · 2021
    Article
  7. Article
  8. Lipoxin ACell death & disease · 2020
    Article
  9. Glucocorticoid Exposure Induces PreeclampsiaFrontiers in pharmacology · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?Hypertension research : official journal of the Japanese Society of Hypertension · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roy J SobermanRenal Unit and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 149 Navy Yard, Charlestown, MA 02129, USA. Soberman@helix.mgh.harvard.edu
Peter Christmas

Funding

Pharmacology of 4F Cytochrome P450's (Supplement)R01GM061823 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI SOBERMAN, ROY · 2000 to 2003
$1.4M
The role of the CYP4F3 gene in inflammationK01DK059991 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTMAS, PETER · 2001 to 2003
$317k
NIDDK NIH HHS K01 DK 59991NIGMS NIH HHS R01 GM 061823NIGMS NIH HHS R01 GM061823
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsGlutathione TransferaseHumansLeukotriene C4Leukotriene D4LeukotrienesProstaglandinsGlutathione TransferaseLeukotriene C4leukotriene-C4 synthaseLeukotriene D4LeukotrienesProstaglandins

Identifiers

PMID12697726
PMCPMC152944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.